We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

20 hedge funds and large institutions have $12.1M invested in ProShares Ultra Health Care in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

28% more capital invested

Capital invested by funds: $9.41M → $12.1M (+$2.68M)

5% more funds holding

Funds holding: 1920 (+1)

1.97% more ownership

Funds ownership: 97.38%99.35% (+2%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

RXL Hedge Fund Activity: Q4 2013 in Review

20 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2013, worth a combined $12.1M — up 28% from $9.41M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new RXL positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $2.19M. The largest seller was Cambridge Investment Research Advisors, cutting an estimated $1.14M.

  • 20 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2013, up from 19 in Q3 2013.
  • Funds reported $12.1M of ProShares Ultra Health Care stock for Q4 2013, up 28% quarter-over-quarter.
  • 5 funds opened new ProShares Ultra Health Care positions in Q4 2013 and 3 closed out, a net change of +2 holders.
  • The largest ProShares Ultra Health Care buyer in Q4 2013 was Susquehanna International Group, an estimated $2.19M added.
  • The largest ProShares Ultra Health Care seller in Q4 2013 was Cambridge Investment Research Advisors, an estimated $1.14M sold.

Based on aggregated 13F filings for Q4 2013.